Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 17 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

20%

2 of 10 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

6Total
Not Applicable (3)
P 1 (1)
P 2 (2)

Trial Status

Completed10
Recruiting4
Unknown1
Not Yet Recruiting1
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 10 completed trials

Clinical Trials (17)

Showing 17 of 17 trials
NCT06491615Recruiting

National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases

NCT05954403Recruiting

National Cohort on Congenital Defects of the Eye

NCT05400590RecruitingPrimary

Comparison of the Healing Properties on Corneal Cells of Groth Factor-enriched Plasma and Autologous Serum From Aniridia Patients

NCT01793168Recruiting

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

NCT03461978Not ApplicableCompleted

Ultrahigh-resolution Optical Coherence Tomography Imaging of the Anterior Eye Segment Structures

NCT05044598Phase 1CompletedPrimary

RAFT - Clinical Trial of RAFT for Aniridia Related Keratopathy

NCT05562115Not ApplicableCompletedPrimary

Proteomic Study of Tears From Patients With a PAX6 Mutation

NCT06412718Not Yet Recruiting

Validation of Human Drugs Target of Repurposed Drugs and Novel Therapies

NCT02647359Phase 2CompletedPrimary

Study of Ataluren in Participants With Nonsense Mutation Aniridia

NCT00812708Not ApplicableCompletedPrimary

Clinical Evaluation of Morcher Artificial Iris Diaphragms

NCT00503893Unknown

Genetics of Wilms' Tumor and/or the Associated Conditions of Aniridia, Hemihypertrophy, and Genitourinary Anomalies

NCT00758108Completed

Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions

NCT01644552CompletedPrimary

Positive Angle Kappa

NCT04117880Phase 2WithdrawnPrimary

A Phase 2 Open Label Extension Study in Participants With Nonsense Mutation Aniridia

NCT03581864Completed

Clinical Outcomes of Implantationof Black Diaphragm Intraocular Lens in Complete Aniridia and Aphakia Due to Posttraumatic Eye Rupture

NCT00265590CompletedPrimary

Correlation of Gene Abnormalities and Clinical Manifestations of Aniridia

NCT00001161CompletedPrimary

Abnormalities of the Eye's Anterior Chamber, Iris, Cornea and Lens

Showing all 17 trials

Research Network

Activity Timeline